¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"leader RNA primed transcription"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse transcription
    ¿ªÀü»ç
  • primed cell
    ÃÊȸ¹Î°¨¼¼Æ÷
  • primed lymphocyte
    ÃÊȸ¹Î°¨¸²ÇÁ±¸
  • primed lymphocyte typing
    ÃÊȸ¹Î°¨¸²ÇÁ±¸Çü°áÁ¤
  • editing RNA
    ÆíÁýRNA
  • immunogen RNA
    ¸é¿ª¿øRNA
  • messenger RNA
    Àü·ÉRNA
  • negative strand RNA
    À½¼º°¡´ÚRNA
  • positive strand RNA
    ¾ç¼º°¡´ÚRNA
  • ribosomal RNA
    ¸®º¸¼ØRNA
  • RNA
    ¸®º¸ÇÙ»ê, RNA
  • RNA splicing
    RNA½ºÇöóÀ̽Ì, ¸®º¸ÇÙ»êÀß¶óÀÌÀ½
  • RNA virus
    RNA¹ÙÀÌ·¯½º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • RNA
    (¢¡ribonucleic acid) ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • RNA virus
    ¾Ë¿£¿¡À̹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reverse transcription
    ¿ªÀü»ç
  • transcription
    ˟ȍ
  • primed cell
    ÃÊȸ°¨ÀÛ¼¼Æ÷
  • primed lymphocyte
    ÃÊȸ¹Î°¨¸²ÇÁ±¸
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    °¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
  • editing RNA
    ÆíÁý¾Ë¿£¿¡ÀÌ
  • immunogen RNA
    ¸é¿ª¿ø¼º¾Ë¿£¿¡ÀÌ
  • messenger RNA
    Àü·É¾Ë¿£¿¡ÀÌ
  • negative strand RNA
    À½¼º°¡´Ú¾Ë¿£¿¡ÀÌ
  • positive strand RNA
    ¾ç¼º°¡´Ú¾Ë¿£¿¡ÀÌ
  • RNA
    (¢¡ribonucleic acid) ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • ribosomal RNA
    ¸®º¸¼Ø¾Ë¿£¿¡ÀÌ
  • RNA splicing
    ¾Ë¿£¿¡ÀÌÂ¥±é±â, ¸®º¸ÇÙ»êÂ¥Áý±â
  • RNA virus
    ¾Ë¿£¿¡À̹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primed
    ÃÊȸ°¨ÀÛ[µÈ]
  • primed
    ÃÊȸÇ׿øÀÚ±Ø(ôøüÞù÷ê«ô§Ð½)À» ¹ÞÀº.
  • primed
    ÃÊȸÇ׿øÀÚ±Ø(ôøüÞù÷ê«í©Ð½)À» ¹ÞÀº
  • primed T cell
    ÃÊȸ°¨ÀÛ T¼¼Æ÷
  • primed lymphocyte
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
  • DNA polymerase, RNA dependent
    RNA- ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA polymerase, RNA-dependent
    RNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-RNA hybridization
    DNA-RNA ¦Áö¿ì±â, DNA-RNA ºÎÇÕ°Ë»ç¹ý(ݬùê~)
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ RNA ÁßÇÕÈ¿¼Ò
  • RNA =>ribonucleic acid
    ¸®º¸ÇÙ»ê
  • RNA editing
    RNA ±³Á¤
  • RNA polymerase
    RNA ÁßÇÕÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leader RNA primed transcription
    ¼±µµ RNA ½Ã¹ßÀü»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • messenger RNA =m RNA
    Àü·É¸®º¸ÇÙ»ê(îîç©¡­ú·ß«).
  • messenger RNA =m RNA
    Àü·É RNA(îîç©¡­ú·ß«).
  • t-RNA => transfer RNA
    ÀüÀÌ RNA
  • transfer RNA =t. RNA
    Àü´Þ RNA.
  • chimeric transcription tactor
  • reverse transcription
    ¿ªÀü»ç
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ).
  • transcription
    ˟ȍ
  • transcription factor
    Àü»çÀÎÀÚ
  • transcription factor II
  • cell, primed T
    ÃÊȸ°¨ÀÛ T¼¼Æ÷
  • primed
    ÃÊȸÇ׿øÀÚ±Ø(ôøüÞù÷ê«ô§Ð½)À» ¹ÞÀº.
  • primed
    ÃÊȸÇ׿øÀÚ±Ø(ôøüÞù÷ê«í©Ð½)À» ¹ÞÀº
  • primed
    ÃÊȸ°¨ÀÛ[µÈ]
  • primed T cell
    ÃÊȸ°¨ÀÛ T¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primed cell
    °¨ÀÛ¼¼Æ÷(ÊïíÂá¬øà)
  • primed synthesis method
    ±âÆø ÇÕ¼º¹ý(ÑÃøïùêà÷Ûö)
  • leader
    ¼±µµÀÚ(à»Óôí­)
  • leader peptide
    ¼±µµ(à»Óô) ÆéŸÀ̵å
  • leader protein
    ¼±µµ´Ü¹éÁú(à»ÓôÓ±ÛÜòõ)
  • leader sequence
    ¼±µµ¼­¿­(à»ÓôßíÖª)
  • leader sequence peptide
    ¼±µµ¼­¿­(à»ÓôßíÖª) ÆéŸÀ̵å
  • asymmetric transcription
    ºÒ±Õµî Àü»ç (ÝÕгÔõï®ÞÐ)
  • coupled transcription-translation
    µ¿½Ã Àü»ç¹ø¿ª(ÔÒãÁï®ÞÐÛèæ»)
  • divergent transcription
    ºÐÁö Àü»ç(ÝÂò«ï®ÞÐ)
  • reverse transcription
    ¿ªÀü»ç(æ½ï®ÞÐ)
  • rRNA transcription unit
    rRNA Àü»ç ´ÜÀ§(ï®ÞÐÓ¤êÈ)
  • symmetric transcription
    ´ëĪÀü»ç (Óßöàï®ÞÐ)
  • transcription
    Àü»ç(ï®ÞÐ)
  • transcription initiation frquency
    Àü»ç°³½Ãºóµµ(ï®ÞÐËÒã·ÞºÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transcription
    º¹»ç, Àü»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PLT pancreatic lymphocytic infiltration; platelet; primed lymphocyte test; primed lymphocyte typing; psi...
PLT Primed Lymphocyte Typing
MORAC mixed oligonucleotides primed amplification of complementary deoxyribonucleic acid
RNA Ribo-Nucleic Acid
HARS histidyl-RNA synthetase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SL 5'-spliced leader
L leader
D RNA defective RNA
HCV RNA Hepatitis C virus RNA
hn-RNA Heteronuclear RNA
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primed
    ÃÊȸ Ç׿ø ÀÚ±ØÀ» ¹ÞÀº
    ÃÖÃÊÀÇ Ç׿ø ÀÚ±ØÀ» ¹ÞÀº °á°ú ¸é¿ªÇÐÀûÀ¸·Î Ȱ¼ºÈ­ÇÏ´Â. ¸é¿ª°èÀÇ ¼¼Æ÷¿¡ °üÇÏ¿© »ç¿ëµÇ´Â ¿ë¾î.
  • reverse transcription
    ¿ªÀü»ç
  • RNA virus
    ¸®º¸ ¹ÙÀÌ·¯½º
  • transfer RNA
    Àü´Þ RNA
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
leader A sequence near the 5' end of an RNAstrand or the amino terminus of a protein that functions intargeting or regulation.
(09 Oct 1997)
leader peptide <molecular biology> In the regulation of gene expression for enzymes concerned with amino acid synthesis in prokaryotes, the leader sequence codes for the leader peptide that contains several residues of the amino acid being regulated. Transcription is closely linked to translation and if translation is retarded by limited supply of amino acyl tRNA for the specific amino acid, the mode of transcription of the leader sequence permits full transcription of the operon genes, otherwise complete transcription of the leader sequence prematurely terminates transcription of the operon.
(18 Nov 1997)
leader sequence <molecular biology> In the regulation of gene expression for enzymes concerned with amino acid synthesis in prokaryotes, the leader sequence codes for the leader peptide that contains several residues of the amino acid being regulated. Transcription is closely linked to translation and if translation is retarded by limited supply of amino acyl tRNA for the specific amino acid, the mode of transcription of the leader sequence permits full transcription of the operon genes, otherwise complete transcription of the leader sequence prematurely terminates transcription of the operon.
(18 Nov 1997)
leader sequences Sequences at the end of either nucleic acids (DNA and RNA) or proteins that must be processed off to allow for a specific function of the mature molecule.
(05 Mar 2000)
reverse transcription <molecular biology> The process of copying information found in RNA into DNA.
(09 Oct 1997)
transcription <molecular biology> Synthesis of RNA by RNA polymerases using a DNA template.
(18 Nov 1997)
transcription factor <molecular biology> Protein required for recognition by RNA polymerases of specific stimulatory sequences in eukaryotic genes.
Several are known that activate transcription by RNA polymerase II when bound to upstream promoters.
Transcription of the 5S RNA gene in Xenopus by RNA polymerase III is dependent on a 40 kD protein TFIIIA that binds to a regulatory site in the centre of the gene and was the first protein found to exhibit the metal binding domains known as zinc fingers.
(17 Mar 1998)
transcription factor ap-1 A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerise in order to bind to the ap-1 recognition site, also known as the tpa-responsive element (tre). Ap-1 controls both basal and inducible transcription of several genes.
(12 Dec 1998)
transcription factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
(12 Dec 1998)
transcription factor, sp1 Promoter-specific RNA polymerase II transcription factor that binds to the gc box, one of the upstream promoter elements (upe) in mammalian cells. The binding of sp1 is necessary to initiate transcription in the promoters of a variety of cellular and viral genes including c-ha-ras and HIV.
(12 Dec 1998)
transcription factors, tfii The so-called general transcription factors that bind to RNA polymerase II and that are required to initiate transcription. They include tfiia, tfiib, tfiid, tfiie, tfiif, tfiih, tfii-I, and tfiij. In vivo they apparently bind in an ordered multi-step process and/or may form a large preinitiation complex called RNA polymerase II holoenzyme.
(12 Dec 1998)
transcription factors, tfiii Factors that bind to RNA polymerase III and aid in transcription. They include the assembly factors tfiiia and tfiiic and the initiation factor tfiiib. All combine to form a preinitiation complex at the promotor that directs the binding of RNA polymerase III.
(12 Dec 1998)
transcription, genetic The transfer of genetic information from DNA to messenger RNA by DNA-directed RNA polymerase. It includes reverse transcription and transcription of early and late genes expressed early in an organism's life cycle or during later development.
(12 Dec 1998)
transcription unit <molecular biology> A region of DNA that is transcribed to produce a single primary RNA transcript, i.e. A newly synthesised RNA molecule that has not been processed.
Transcription units can be mapped by kinetic studies of RNA synthesis and in some instances directly visualised by electron microscopy.
(17 Mar 1998)
erythroid transcription factor <molecular biology> Transcription factor that binds to regulatory regions of genes expressed in erythroid cells.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transcription
    ˟ȍ
  • electrical transcription
    ³ìÀ½ ¹æ¼Û¿ä(·¹ÄÚµå,Å×ÀÌÇÁ);³ìÀ½
  • transcription
    ÇÊ»ç;¸ð»ç;º¹»ç;¹Ù²ã ¾¸;Àü»ç;¹Ù²ã¾´ °Í
  • RNA
    ¸®º¸ ÇÙ»ê
  • RNA polymerase
    RNA Æ÷¸®¸Þ¶óÁ¦(¸®º¸ÇÙ»ê ÇÕ¼ºÈ¿¼Ò)
  • RNA replicase
    RNA ·¹Çø®Ä«Á¦(RNAÇÕ¼ºÈ¿¼Ò)
  • heteronuclear RNA
    ÀÌÇÙ¸®º¸ ÇÙ»ê
  • messenger RNA
    ¸Þ½ÅÀú ¸®º¸ ÇÙ»ê
  • ribosomal RNA
    ¸®º¸¼Ø ¸®º¸ ÇÙ»ê(¼¼Æ÷ÁúÀÇ Çٴܹé ÀÔÀÚ ¾È¿¡ ÀÖ´Â ¸®º¸ ÇÙ»ê)
  • transfer RNA
    ÀüÀÌ RNA;¿î¹Ý RNA
  • leader
    ÁöµµÀÚ
  • bear leader
    °¡Á¤±³»ç
  • cattle-leader
    ¼èÄÚ¶Ñ·¹
  • destroyer leader
    Çâµµ ±¸ÃàÇÔ
  • district leader
    (¹Ì)Á¤´çÀÇ Áö¹æ ÁöºÎÀå
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á